PPT-Real-world examples of FTC to CAM transformations

Vesa Juvonen Principal Consultant Microsoft Steve Walker SR Program Manager Microsoft Vesa Juvonen PreMicrosoft Entrepreneur ICL Fujitsu Basware Software Architect Project manager program manager Developer Casino dealer and middle manager substitute teacher in high school Hamburger joint worker. Ch. 2 Lesson 3. Pg. 123. What will you will learn?. Enlarge Photographs. Make something from a pattern. Identify Similarity. Two figures are . similar. if the second can be obtained from the first by a sequence of transformations and dilations. in real life. HW: Maintenance Sheet 3 . (7-8). I can use the properties of translations, rotations, and reflections on line segments, angles, parallel lines or geometric figures. . I can show and explain two figures are congruent using transformations (explaining the series of transformations used) . Cam – driver; Follower - driven . In a cam - follower pair, the cam normally rotates while the follower may translate or oscillate. . Cams are used to convert rotary motion into reciprocating motion. We return briefly to the Intel and MIPS architectures from the last chapter, using some of the ideas introduced in this chapter.. Intel introduced pipelining to their processor line with its Pentium chip.. . 16-385 Computer Vision. Spring 2019, . Lecture 7. http://www.cs.cmu.edu/~16385/. Course announcements. Homework 2 is posted on the course website.. - It is due on February 27. th. at 23:59 pm.. - Start early because it is much larger and more difficult than homework 1.. almost-inevitable patent infringement lawsuit from the brand-name manufacturer By weaken and undermine the incentive for generic manufacturers to take those risks Undermining ss in the Hatch Waxman Study 1249. Elvitegravir-Cobicistat-TAF-FTC in HIV/HBV Coinfection . Study 1249: . Design. Source: Gallant J, et al. . J. . Acquir. Immune . Defic. . Syndr. . 2016;73:294-8.. Baseline ART. (n = 72). CS5670: Computer Vision. Reading. Szeliski. : Chapter 3.6. Announcements. Project 2 out, due Thursday, March 3 by 8pm. Do be done in groups of 2 – if you need help finding a partner, try Ed Discussions or let us know. GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . versus . DTG + TDF-FTC as Initial ART. GEMINI 1 and 2: Background. Source: Cahn P, et al. Lancet. 2019;393:143-55.. Study Design: GEMINI 1 and 2. Background. ADVANCE. . Design. Primary endpoint. Proportion of patients with HIV RNA < 50 c/mL at W48, ITT-E snapshot analysis ; non-inferiority of TFA/FTC if lower margin CI for . the difference = - 10%, 80% power. FTC. Study 311-1089. Switching from TDF/FTC to TAF/. FTC. Study 311: Design. Source. : Gallant JE, et al. Lancet HIV. 2016;3:e158-65.. Switch to TAF/FTC*. . (n = 333). Continue TDF/FTC. (n = 330). *Patients on a pharmacokinetic booster (ritonavir) received tenofovir alafenamide-emtricitabine 10/200 mg. Andrew Hill, Francois Venter, Eric . Delaporte. , . Simiso. Sokhela, Charles . Kouanfack. , . Michelle Moorhouse. , Kaitlyn McCann, Bryony Simmons. , . Alexandra . Calmy. Disclosures. Speaker fees and honoraria from Gilead Sciences, AbbVie, Cipla, Johnson and Johnson, Sanofi, Pfizer, ViiV Healthcare, Mylan and Southern African HIV Clinicians Society. Study 112. Elvitegravir-Cobicistat-TAF-FTC in Renal Impairment. Study 112: . Design. Source: . Pozniak. A, et al. J . Acquir. Immune . Defic. . Syndr. . 2016;71:530-7.. Baseline ART*. (n = 242). Study Design: Study 112. SWEET Trial . Switch to Efavirenz + TDF-FTC . SWEET: Study Design. Source: Fisher M, et al. . J Acquir Immune Defic Syndr. 2009;51:562-8.. Background. : Randomized, . controlled, open-label, phase 3 trial evaluating a simplification strategy for patients suppressed .